Biliary cystadenoma and cystadenocarcinoma overview

Revision as of 22:33, 6 June 2019 by Ahmed Younes (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Biliary cystadenoma and cystadenocarcinoma Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Biliary cystadenoma and cystadenocarcinoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Biliary cystadenoma and cystadenocarcinoma overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Biliary cystadenoma and cystadenocarcinoma overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Biliary cystadenoma and cystadenocarcinoma overview

CDC on Biliary cystadenoma and cystadenocarcinoma overview

Biliary cystadenoma and cystadenocarcinoma overview in the news

Blogs on Biliary cystadenoma and cystadenocarcinoma overview

Directions to Hospitals Treating Biliary cystadenoma and cystadenocarcinoma

Risk calculators and risk factors for Biliary cystadenoma and cystadenocarcinoma overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Suveenkrishna Pothuru, M.B,B.S. [2]

Overview

Biliary cystadenoma is an uncommon unilocular or multilocular cystic neoplasm that usually arises in the liver or occasionally in the extrahepatic biliary tree and gallbladder. Biliary cystadenomas constitute less than 5% of cystic lesions of the liver. On gross pathology, biliary cystadenoma is unilocular or multilocular cystic lesion filled with fluid or blood. Cystic fluid may be clear and mucinous. On microscopic histopathological analysis, presence of biliary-type epithelium wall supported by ovarian-like stroma is characteristic finding of biliary cystadenoma. The cause of biliary cystadenoma has not been identified. However, it is thought to occur either as a result of the development of ectopic foci of primitive foregut sequestered within the liver or due to the obstruction of the congenitally aberrant bile duct. Neoplastic transformation to cystadenocarcinoma is the most common complication of biliary cystadenoma. Biliary cystadenoma with mesenchymal stroma is associated with most favorable prognosis. Symptoms of biliary cystadenoma include abdominal pain in right upper quadrant, abdominal distension, abdominal mass, nausea, and vomiting. Common physical examination findings of biliary cystadenoma are a palpable, tender mass in the right upper quadrant of abdomen or epigastrium, jaundice, and ascites. On ultrasound, biliary cystadenoma is characterized by fluid filled multiloculated cyst with enhanced transmission. The cyst fluid may contain low level echoes from blood products, mucin, or proteinaceous fluid. Contrast-enhanced ultrasound demonstrates minimal enhancement since the tumors are largely avascular. Surgical resection of tumor is the mainstay of treatment for biliary cystadenoma. Complete enucleation of the cyst is a safe and effective treatment for biliary cystadenoma and hepatic resection is a suitable treatment option for biliary cystadenocarcinoma.

Classification

There is no classification system established for biliary cystadenoma and biliary cystadenocarcinoma.

Pathophysiology

On gross pathology, biliary cystadenoma is unilocular or multilocular cystic lesion filled with fluid. Cystic fluid may be clear and mucinous. On microscopic histopathological analysis, presence of biliary-type epithelium wall, occasional papillary projections, and ovarian-like stroma are characteristic findings of biliary cystadenoma.

Causes

The cause of biliary cystadenoma has not been identified. However, it is thought to occur either as a result of the development of ectopic foci of primitive foregut sequestered within the liver or due to the obstruction of the congenitally aberrant bile duct.

Differential Diagnosis

Biliary cystadenoma and cystadenocarcinoma must be differentiated from simple liver cysts, liver hematoma, hepatic echinococcal cyst, hepatic abscess, post-traumatic cysts, and bilomas.

Epidemiology and Demographics

Biliary cystadenoma is a rare disease. Females are more commonly affected with biliary cystadenoma than males. The median age at diagnosis of biliary cystadenoma is 45 years.

Risk Factors

There are no established risk factors for biliary cystadenoma.

Screening

According to the the U.S. Preventive Service Task Force (USPSTF), there is insufficient evidence to recommend routine screening for biliary cystadenoma.

Natural History, Complications and Prognosis

Common complication of biliary cystadenoma include neoplastic transformation to biliary cystadenocarcinoma. Biliary cystadenoma with mesenchymal stroma is associated with most favorable prognosis.

Diagnosis

Staging

There is no established system for the staging of biliary cystadenoma and biliary cystadenocarcinoma.

History and Symptoms

Symptoms of biliary cystadenoma include abdominal pain in right upper quadrant, abdominal distension, abdominal mass, nausea, and vomiting.

Physical Examination

Common physical examination findings of biliary cystadenoma are a palpable, tender mass in the right upper quadrant of abdomen or epigastrium, jaundice, and ascites.

Laboratory Findings

Laboratory findings consistent with the diagnosis of biliary cystadenoma include elevation of serum alkaline phosphatase, serum bilirubin, and CA 19-9 in cystic fluid. Some patients with biliary cystadenoma may have leukocytosis with left shift, which is usually suggestive of superinfection of the tumor.

CT

On CT scan, biliary cystadenoma is characterized by fluid filled multiloculated cyst with calcification of septa and cyst wall. The appearance of the cyst fluid on CT is variable depending on its composition.

MRI

Abdominal MRI may be helpful in the diagnosis of biliary cystadenoma, which demonstrates variability on T1-and T2-weighted images.

Ultrasound

On ultrasound, biliary cystadenoma is characterized by fluid filled multiloculated cyst with enhanced transmission. The cyst fluid may contain low level echoes from blood products, mucin, or proteinaceous fluid. Contrast-enhanced ultrasound demonstrates minimal enhancement since the tumors are largely avascular.

Treatment

Medical Therapy

There is no medical therapy for biliary cystadenoma and cystadenocarcinoma. The mainstay of therapy is surgical resection.

Surgery

Surgical resection of tumor is the mainstay of treatment for biliary cystadenoma. Complete enucleation of the cyst is a safe and effective treatment for biliary cystadenoma and hepatic resection is a suitable treatment option for biliary cystadenocarcinoma.

References

Template:WikiDoc Sources